Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,547 | 875 | 99.8% |
| Education | $26.31 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,697 | 133 | $0 (2024) |
| Amgen Inc. | $1,137 | 70 | $0 (2024) |
| Lilly USA, LLC | $1,136 | 85 | $0 (2024) |
| Novo Nordisk Inc | $1,023 | 69 | $0 (2024) |
| GlaxoSmithKline, LLC. | $789.97 | 60 | $0 (2024) |
| PFIZER INC. | $641.92 | 50 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $595.37 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $535.36 | 38 | $0 (2024) |
| Allergan, Inc. | $438.51 | 40 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $422.31 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,199 | 134 | ABBVIE INC. ($451.73) |
| 2023 | $1,683 | 104 | ABBVIE INC. ($486.76) |
| 2022 | $1,638 | 115 | ABBVIE INC. ($374.48) |
| 2021 | $2,030 | 132 | AbbVie Inc. ($365.67) |
| 2020 | $1,306 | 92 | Allergan, Inc. ($312.19) |
| 2019 | $1,005 | 82 | GlaxoSmithKline, LLC. ($144.56) |
| 2018 | $1,048 | 80 | AstraZeneca Pharmaceuticals LP ($131.85) |
| 2017 | $1,665 | 141 | Lilly USA, LLC ($159.04) |
All Payment Transactions
880 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bard Peripheral Vascular, Inc. | Venclose Maven Catheter (Device) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Vascular/Oncology | ||||||
| 12/13/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: PAIN | ||||||
| 12/02/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Cardiology | ||||||
| 11/27/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Bone Health | ||||||
| 11/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: VACCINES | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: PAIN | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: UROLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Bone Health | ||||||
| 10/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: PAIN | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Inflammation | ||||||
| 09/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 824 | 1,058 | $113,273 | $62,926 |
| 2022 | 15 | 936 | 1,146 | $115,989 | $66,071 |
| 2021 | 18 | 911 | 1,256 | $120,909 | $71,700 |
| 2020 | 18 | 1,163 | 1,595 | $172,057 | $83,317 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 300 | $54,900 | $25,867 | 47.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 122 | 122 | $18,300 | $15,556 | 85.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 128 | $16,512 | $7,707 | 46.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 38 | 39 | $3,250 | $2,951 | 90.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 107 | 107 | $5,350 | $2,729 | 51.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 15 | $3,975 | $2,414 | 60.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 117 | 117 | $4,095 | $2,139 | 52.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 112 | 112 | $3,920 | $2,047 | 52.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 40 | $1,600 | $1,206 | 75.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 25 | 43 | $516.00 | $133.73 | 25.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $648.00 | $125.29 | 19.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 23 | $207.00 | $50.60 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 147 | 283 | $51,789 | $24,069 | 46.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 129 | 129 | $19,350 | $17,048 | 88.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 142 | $18,318 | $9,058 | 49.4% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 115 | 115 | $5,750 | $3,047 | 53.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 43 | 43 | $3,440 | $3,021 | 87.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 126 | 126 | $4,410 | $2,380 | 54.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 118 | 118 | $4,130 | $2,188 | 53.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 46 | 46 | $1,830 | $1,350 | 73.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 28 | 31 | $1,860 | $1,082 | 58.2% |
| 77067 | Screening mammography | Office | 2022 | 11 | 11 | $1,716 | $1,046 | 61.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 17 | 19 | $1,805 | $972.95 | 53.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $510.00 | $384.12 | 75.3% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 11 | 11 | $451.00 | $265.41 | 58.8% |
About Dr. Herbert King, MD
Dr. Herbert King, MD is a Family Medicine healthcare provider based in Midlothian, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568414092.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Herbert King, MD has received a total of $12,574 in payments from pharmaceutical and medical device companies, with $2,199 received in 2024. These payments were reported across 880 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($12,547).
As a Medicare-enrolled provider, King has provided services to 3,834 Medicare beneficiaries, totaling 5,055 services with total Medicare billing of $284,014. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Midlothian, VA
- Active Since 05/16/2006
- Last Updated 07/19/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1568414092
Products in Payments
- VRAYLAR (Drug) $894.61
- JARDIANCE (Drug) $722.13
- UBRELVY (Drug) $530.01
- QULIPTA (Drug) $528.29
- TRELEGY ELLIPTA (Drug) $466.95
- EMGALITY (Drug) $397.09
- TRULICITY (Drug) $395.91
- NURTEC ODT (Drug) $387.72
- Otezla (Drug) $333.11
- Ozempic (Drug) $328.78
- EVENITY (Biological) $309.84
- XIFAXAN (Drug) $275.94
- TRINTELLIX (Drug) $234.92
- Aimovig (Biological) $223.01
- Wegovy (Drug) $221.24
- XARELTO (Drug) $207.08
- FARXIGA (Drug) $202.63
- CONTRAVE (Drug) $180.78
- Prolia (Biological) $179.13
- Trintellix (Drug) $175.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Midlothian
Donald Sanders, M.d, M.D
Family Medicine — Payments: $18,297
Joseph Goddard, M.d, M.D
Family Medicine — Payments: $17,178
Dr. Joseph Castro, D.o, D.O
Family Medicine — Payments: $14,548
William Morrissette, M.d, M.D
Family Medicine — Payments: $13,896
Dr. Laura Aisenberg, M.d, M.D
Family Medicine — Payments: $13,402
Damian Covington, M. D, M. D
Family Medicine — Payments: $12,759